The chemistry of the metabolites of cyclophosphamide

Current Pharmaceutical Design

Volumn 5, Issue 8, 1999, Pages 627-643

  Ludeman, Susan M ^a  

^a DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYCYCLOPHOSPHAMIDE; ACROLEIN; ALDOPHOSPHAMIDE; CHLORMETHINE DERIVATIVE; CHLOROETHYLAZIRIDINE; CYCLOPHOSPHAMIDE DERIVATIVE; DRUG METABOLITE; IMINOPHOSPHAMIDE; PHOSPHORAMIDE MUSTARD; UNCLASSIFIED DRUG;

CHEMICAL REACTION; DRUG ACTIVITY; DRUG METABOLISM; DRUG STRUCTURE; ENZYME REGULATION; HUMAN; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; HUMANS;

EID: 0032849465     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Pratt, W.B.; Ruddon, R.W.; Ensminger, W.D.; Maybaum, J. The Anticancer Drugs; Oxford University Press: New York, 1994; pp 17-18, 108-112.
2. Gilman, A.; Phillips, F.S. Science 1946, 103, 409.
3. Colvin, M. Cancer Medicine, 3rd ed.; Holland, J.F., Frei, E., Kufe, D.W., Morton, D.L., Weichselbaum, R.R. Eds.; Lea & Febiger: Malvern, PA, 1991; pp 733-754.
4. Colvin, M.; Chabner, B.A. Cancer Chemotherapy: Principles and Practice; Chabner, B.A., Collins. J.M., Eds.; J.L. Lippincott: Philadelphia. PA, 1991; pp 276-313.
5. Saffhill, R.; Margison, G.P.; O'Connor, P.J. Biochem. Biophys. Acta 1985, 823, 111-145.
6. Gamcsik, M.P.; Millis, K.K.; Hamill, T.G. Chem.-Biol. Interact. 1997, 705, 35-52.
7. Springer, J.B.; Colvin, M.E.; Colvin, O.M.; Ludeman, S.M. J. Org. Chem. 1998, 63, 7218-7222.
8. Colvin, M.; Brundrett, R.B.; Kan, M.-N.N.; Jardine, I.; Fenselau, C. Cancer Res. 1976, 36, 1121-1126.
9. Hausheer, F.H.; Singh, U.C.; Saxe, J.D.; Colvin, O.M. AntiCancer Drug Res. 1989, 4, 281-294.
10. Dong, Q.; Barsky, D.; Colvin, M.E.; Melius, C.F.; Ludeman, S.M.; Moravek, J.F.; Colvin, O.M.; Bigner, D.D.; Modrich, P.; Friedman, H.S. Proc. Nail. Acad. Sci. USA 1995, 92, 12170-12174.
11. Gamcsik, M.P.; Hamill, T.G.; Colvin, M. J. Med. Chem. 1990, 33, 1009-1014.
12. Shulman-Roskes, E.M.; Noe, D.A.; Gamcsik, M.P.; Marlow, A.L.; Hilton, J.; Hausheer, F.H.; Colvin, O.M.; Ludeman, S.M. J. Med. Chem. 1998, 47, 515-529.
13. Lu, H.; Chan, K.K. J. Chromatogr. B: Biomed. Appl. 1996, 678, 219-225.
14. Colvin, M.E.; Sasaki, J.C.; Tran, N.L. Current Pharmaceutical Design 1999, 5, 645-664.
15. Gomori, G. Proc. Soc. Exp. Biol. Med. 1948, 69, 407.
16. Hill, D.L. A Review of Cyclophosphamide; Charles C. Thomas: Springfield, IL, 1975; pp 12-15, 25-26.
17. Arnold, H.; Bourseaux, F. Angew. Chem. 1958, 70, 539.
18. Colvin, O.M. Current Pharmaceutical Design 1999, 5, 555-560.
19. Ludeman, S.M.; Zon, G.; Colvin, O.M.; Gamcsik, M.P.; Shulman-Roskes, E.M. Current Topics Med. Chem. 1993, 1, 155-171.
20. Williams, M.L.; Wainer, I.W. Current Pharmaceutical Design 1999, 5, 665-672.
21. Habib, A.D.; Boal, J.H.; Hilton, J.; Nguyen, T.; Chang, Y.H.; Ludeman, S.M. Biochem. Pharmacol. 1995, 50, 429-433.
22. Ortiz de Montellano, P.R. Cytochrome P450; Ortiz de Montellano, P.R., Ed.; Plenum Press: NY, 1995; pp 271-273.
23. Fenselau, C.; Kan, M.-N.N.; Rao, S.S.; Myles, A.; Friedman, O.M.; Colvin, M. Cancer Res. 1977, 37, 2538-2543.
24. Fenselau, C.; Lehman, J.P.; Myles, A.; Brandt, J.; Yost, G.S.; Friedman, O.M.; Colvin, O.M. Drug Metab. Dispos. 1982, 10, 636-640.
25. Borch, R.F.; Getman, .M. J. Med. Chem. 1984, 27, 485-490.
26. Kwon, C-H.; Borch, R.F.; Engel, J.; Niemeyer, U. J. Med. Chem. 1987, 30, 395-399.
27. Boyd, V.L.; Summers, M.F.; Ludeman, S.M.; Egan, W.; Zon, G.; Regan, J.B. J. Med. Chem. 1987, 30, 366-374.
28. Zon, G.; Ludeman, S.M.; Brandt, J.A.; Boyd, V.L.; Ozkan, G.; Egan, W.; Shao, K.-L. J. Med. Chem. 1984, 27, 466-485.
29. Tolly, D.A. Brit. J. Urol. 1977, 49, 659-661.
30. Gamcsik, M.P.; Dolan, M.E.; Andersson, B.S.; Murray, D. Current Pharmaceutical Design 1999, 5, 587-605.
31. Borch, R.F.; Hoye, T.R.; Swanson, T.A. J. Med. Chem. 1984, 27, 490-494.
32. Low, J.E.; Borch, R.F.; Sladek, N.E. Cancer Res. 1983, 43, 5815-5820.
33. Borch, R.F.; Millard, J.A. J. Med. Chem. 1987, 30, 427-431.
34. Boyd, V.L. Kinetic Studies of Preactivated Derivatives of Cydophosphamide by 31-P NMR Spectroscopy, Ph.D. Thesis, The Catholic University of America, Washington, D.C. 1985.
35. Ludeman, S.M.; Boyd, V.L.; Regan, J.B.; Gallo, K.A.; Zon, G.; Ishii, K. Drugs Exptl. Clin. Res. 1986, 12, 527-532.
36. Ludeman, S.M.; Boyd, V.L.; Regan, J.B.; Gallo, K.A.; Zon, G. J. Med. Chem. 1986, 29, 716-727.
37. Habib, A.D. Biological Stereochemistry, Ph.D. Thesis, The Catholic University of America, Washington, D.C. 1991.
38. Borch, R.F.; Canute, G.W. J. Med. Chem. 1991, 34, 3044-3052.
39. Connors, T.A.; Cox, P.J.; Farmer, P.B.; Foster, A.B.; Jarman, M.; Macleod, J.K. Biomed. Mass Spectrom. 1974, 7, 130-136.
40. Peter, G.; Hohorst, H.-J. Cancer Chemother. Pharmacol. 1979, 3, 181-188.
41. Boal, J.H.; Ludeman, S.M.; Ho, C.-K.; Engel, J.; Niemeyer, U. Arzneim.-Forsch./Drug Res. 1994, 44, 84-93.
42. Brock, N.; Hilgard, P.; Peukert, M.; Pohl, J.; Sindermann, H. Cancer Invest. 1988, 6, 513-532.
43. Dirven, H.A.A.M.; Venekamp, J.C.; van Ommen, B.; van Bladeren, P.J. Chem.-Biol. Interact. 1994, 93, 185-196.
44. Hong, P.S.; Chan, K.K. J. Chromatog. 1989, 495, 131-138.
45. Zon, G.; Ludeman, S.M.; Sweet, E.M.; Egan, W.; Phillips, L.R. J. Pharm. Sci. 1982, 77, 443-446.
46. Ludeman, S.M.; Shulman-Roskes, E.M.; Wong, K.T.; Han, S.Y.; Anderson, L.W.; Strong, J.M.; Colvin, O.M. J. Pharm. Sci. 1995, 84, 393-398.
47. Sladek, N.E. Cancer Res. 1973, 33, 651-658.
48. Malet-Martino, M.; Guard, V.; Martino, R. Current Pharmaceutical Design 1999, 5, 561-686.
49. Sladek, N.E. Current Pharmaceutical Design 1999, 5, 607-625.
50. Ludeman, S.M.; Ho, C.-K.; Boal, J.H.; Sweet, E.M.; Chang, Y.H. Drug Metab. Dispos. 1992, 20, 337-338.
51. Engle, T.W.; Zon, G.; Egan, W. J. Med. Chem. 1982, 25, 1347-1357.
52. Boal, J.H.; Williamson, M.; Boyd, V.L.; Ludeman, S.M.; Egan, W. J. Med. Chem. 1989, 32, 1768-1773.
53. Watson, E.; Dea, P.; Chan, K.K. J. Pharm. Sci. 1985, 74, 1283-1292.
54. Boyd, V.L.; Robbiris, J.D.; Egan, W.; Ludeman, S.M. J. Med. Chem. 1986, 29, 1206-1210.
55. Gamcsik, M.P.; Ludeman, S.M.; Shulman-Roskes, E.M.; McLennan, I.J.; Colvin, M.E.; Colvin, O.M. J. Med. Chem. 1993, 36, 3636-3645.
56. Kwon, C.H.; Moon, K.-Y.; Baturay, N.; Shirota, F.N. J. Med. Chem. 1991, 34, 588-592.
57. Emsley, J.; Hall, D. The Chemistry of Phosphorus; John Wiley & Sons: New York, 1976; p 382.
58. Chan, K.K.; Hong, P.S.; Tutsch, K.; Trump, D.L. Cancer Res. 1994, 54, 6421-6429.
59. Hong, P.S.; Srigritsanapol, A.; Chan, K.K. Drug Metab. Dispos. 1991, 79, 1-7.
60. Jardine, I.; Fenselau, C.; Appler, M.; Kan, M.-N.; Brundrett, R.B.; Colvin, M. Cancer Res. 1978, 38, 408-415.
61. Bolton, M.G.; Hilton, J.; Robertson, K.D.; Streeper, R.T.; Colvin, O.M.; Noe, D.A. Drug Metab. Disp. 1993, 21, 986-996.
62. Yuan, Z.-M.; Smith, P.B.; Brundrett, R.B.; Colvin, M.; Fenselau, C. Drug Metab. Disp. 1991, 79, 625-629.
63. Sladek, N.E.; Powers, J.F.; Grage, G. Drug Metab. Dispos. 1984, 12, 553-559.
64. Kwon, C.H.; Maddison, K.; LoCastro, L.; Borch, R.F. Cancer Res. 1987, 47, 1505-1508.
65. Friedman, H.S.; Pegg, A.E.; Johnson, S.; Loktionova, N.A.; Dolan, M.E.; Modrich, P.; Moschel, R.C.; Struck, R.; Brent, T.; Ludeman, S.; Bullock, N.; Kilborn, C.; Keir, S.; Dong, Q.; Bigner, D.D.; Colvin, O.M. Cancer Chemother. Pharmcaol. 1999, 43, 80-85.
66. Cai, Y.; Wu, M.H.; Ludeman, S.M.; Grdina, D.J.; Dolan, M.E. Cancer Res. 1999, 59, 3059-3063.